1. 100986-89-8
2. Levofloxacin Carboxylic Acid
3. (s)-9,10-difluoro-3-methyl-7-oxo-3,7-dihydro-2h-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic Acid
4. Levofloxacin Related Compound B
5. Levofloxacin Q-acid, (-)-
6. 08gt8fy84e
7. (2s)-6,7-difluoro-2-methyl-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic Acid
8. (s)-(-)-9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-7h-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic Acid
9. 7h-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic Acid, 9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-, (3s)-
10. Ofloxacin Impurity A
11. (s)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid
12. Unii-08gt8fy84e
13. 8,9-difluoro-3-methyl-6-oxo-2,3-dihydro-6h-1-oxa-3a-aza-phenalene-5-carboxylic Acid
14. (s)-(-)-9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-7h-pyrido-[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid
15. 7h-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid, 9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-, (3s)-
16. Levofloxacin Related Compound B [usp]
17. Levofloxacin Impurity F
18. Levofloxacin Related Compound B Rs [usp]
19. Schembl2333806
20. Zinc57096
21. Dtxsid60143604
22. Chebi:167723
23. Mfcd04039905
24. Akos016002127
25. Ac-7592
26. Fs-4544
27. (3s)-9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-7h-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid
28. (s)-(-)-9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-7h-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid
29. Cs-0136444
30. L0238
31. 86d898
32. N17092
33. Levofloxacin Related Compound B [usp-rs]
34. A897275
35. Levofloxacin Related Compound B [usp Impurity]
36. Q27236408
37. Levofloxacin Hemihydrate Impurity F [ep Impurity]
38. 8,9-difluoro-3-methyl-6-oxo-2,3-dihydro-6h-1-oxa-3a-azaphenalene-5-carboxylic Acid
39. Levofloxacin Related Compound B, United States Pharmacopeia (usp) Reference Standard
40. (-) -9,10-difluoro-3(s)-methyl-7-oxo-2,3-dihydro-7h -pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid
41. (-) -9,10-difluoro-3(s)-methyl-7-oxo-2,3-dihydro-7h-pyrido [1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid
42. (-)-9,10-difluoro-3(s)-methyl-7-oxo-2,3-dihydro-7h-pyrido [1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid
43. (-)-9,10-difluoro-3(s)-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid
44. (3s)-9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-7h-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic Acid
45. (3s)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7h-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic Acid
46. (s)-(-) 9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de][1,4] Benzoxazine-6-carboxylic Acid
47. (s)-(-)-9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-7h-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid 97%
48. (s)-(-)-9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-7h-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid, 97%
49. (s)-(-)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido [1,2,3-de] [1,4]benzoxazine-6-carboxylic Acid
50. (s)-(-)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido [1,2,3-de][1,4]benzoxazine-6-carboxylic Acid
51. (s)-(-)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid
52. (s)-(-)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic Acid
53. (s)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic Acid
54. 6,7-diluoro-2-methyl-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic Acid
55. 9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-(3s)-7h-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid
Molecular Weight | 281.21 g/mol |
---|---|
Molecular Formula | C13H9F2NO4 |
XLogP3 | 2.1 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 1 |
Exact Mass | 281.04996409 g/mol |
Monoisotopic Mass | 281.04996409 g/mol |
Topological Polar Surface Area | 66.8 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 495 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
BUILDING BLOCK
CAS Number : 100986-89-8
End Use API :
End Use API : Levofloxacin, Pazufloxacin Mesylate
About the Company : Chengda Pharmaceutical Co., Ltd. was founded in 1999. It is located in the Hangzhou-Jiaxing-Huzhou plain, Jiashan Economic & Technological Development Zone (national level). The company...
TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
DKSH is your trusted partner for companies looking to grow their business in Asia & beyond.
HRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.
MARKET PLACE
Reply
22 Jun 2021
LOOKING FOR A SUPPLIER?